Join BOPA
Back to news articles

NICE Breast cancer guidelines expert faculty and NICE Kidney Cancer guidelines committee

By BOPA Committee on 9th August 2023

NICE Breast cancer guidelines expert faculty

NICE Kidney Cancer guidelines committee

 

NICE are recruiting new members for a faculty of breast cancer experts and a new guideline on Kidney cancer. I appreciate everyone is busy with clinical work but do consider applying. These are excellent opportunities to help develop new guidance to improve patient care.

https://www.nice.org.uk/get-involved/our-committees/join-a-committee/member–breast-cancer-guideline-updates-expert-faculty

https://www.nice.org.uk/get-involved/our-committees/join-a-committee/member–kidney-cancer-committee

Best wishes

Jeremy

Dr Jeremy Braybrooke (he/him)
Consultant Clinical Adviser, Clinical Directorate
National Institute for Health and Care Excellence

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article